METHODS	After completing the 12-week randomized , double-blind base study that compared EZE 10 mg , FENO 160 mg , FENO 160 mg plus EZE 10 mg , and placebo in patients with mixed hyperlipidemia , patients continued into a double-blind , 48-week extension phase .\